Skip to content

Clinical Trial Protocol for Safety, Efficacy and Feasibility of Implantable Spinal Cord Stimulator System in the Treatment of Limb Motor Dysfunction After Brain Injury

Clinical Trial Protocol for Safety, Efficacy and Feasibility of Implantable Spinal Cord Stimulator System in the Treatment of Limb Motor Dysfunction After Brain Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108641
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limb motor dysfunction after brain injury

Interventions

Test group:Spinal Cord Electrical Stimulation Synchronized with Artificial Exoskeleton

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) The patient has suffered from brain injury for at least 6 months, accompanied by limb motor dysfunction; (2) The patient's age is between 18 and 70 years old (inclusive); (3) The patient and their family members have a strong willingness to undergo stimulator implantation; (4) The patient has a certain ability to understand and communicate, voluntarily participates in the study, and signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Presence of persistent dyspnea; (2) Presence of language or cognitive impairment; (3) Severe depression (Beck Depression Inventory score >= 16); (4) Current progressive brain disease; (5) Presence of surgical contraindications (e.g., history of adverse reactions to anesthetics, deemed unsuitable for surgery by the surgeon, etc.); (6) Having other implanted stimulation devices in the body (such as cardiac pacemakers or other neurostimulators), or using other investigational devices or drugs; (7) Requirement for thermotherapy currently or during the trial period; (8) Presence of significant joint deformities; (9) Pregnant or lactating women, or patients who cannot take appropriate contraceptive measures during the trial period.

Design outcomes

Primary

MeasureTime frame
The change in the FMA-UE (Fugl-Meyer Assessment for Upper Extremity) motor function score ;

Secondary

MeasureTime frame
The change in motor function as measured by the FMA-UE (Fugl-Meyer Assessment for Upper Extremity) score ;The change in the Modified Ashworth Scale (MAS) for spasticity assessment ;The changes in somatosensory evoked potentials (SSEPs) of the upper and lower limbs ;The changes in motor evoked potentials (MEPs) of the upper and lower limbs ;The changes in electromyography (EMG) tests of the upper and lower limbs ;The changes in electroencephalogram (EEG) tests ;

Countries

China

Contacts

Public ContactWenling Li

The Second Hospital of Hebei Medical University

27104413@hebmu.edu.cn+86 138 3111 7829

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026